| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/17/2010 | EP1928861B1 4- (ih-indazol-5-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer |
| 11/17/2010 | EP1917264B1 Novel 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 11/17/2010 | EP1910400B1 Improved crystalline form of the compound a-348441 |
| 11/17/2010 | EP1899296B1 Histamine-3 receptor antagonists |
| 11/17/2010 | EP1896491B1 Monoazole ligand platinum analogs |
| 11/17/2010 | EP1896399B1 Biphenyl and naphthyl-phenyl hydroxamic acid derivatives |
| 11/17/2010 | EP1871394B1 Anti-inflammatory and/or analgesic composition for the intestine comprising branched maltodextrins |
| 11/17/2010 | EP1838306B1 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 11/17/2010 | EP1797035B1 Cyclopropyl piperidine glycine transporter inhibitors |
| 11/17/2010 | EP1796665B1 Compounds for the treatment of dyslipidemia and other lipid disorders |
| 11/17/2010 | EP1791815B1 Pyrrolidine derivatives acting as ccr3-receptor antagonists |
| 11/17/2010 | EP1778671B1 Piperazine derivatives with ccr3 inhibiting activity |
| 11/17/2010 | EP1755578B1 Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance |
| 11/17/2010 | EP1737856B1 Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol, and applications thereof |
| 11/17/2010 | EP1624899B1 INCREASED TRANSDUCTION USING ABC TRANSPORTER SUBSTRATES that are INHIBITORS |
| 11/17/2010 | EP1599194B1 Use of acetylsalicylic acid for the prophylaxis and/or therapy of viral diseases |
| 11/17/2010 | EP1585525B1 Use of thiazolobenzoheterocycles for treating multiple sclerosis |
| 11/17/2010 | EP1585522B1 Quinazolinones as potassium channel modulators |
| 11/17/2010 | EP1547577B1 Antiaging composition |
| 11/17/2010 | EP1491206B1 Use of peptide derivatives for inducing cell differentiation |
| 11/17/2010 | EP1480616B1 Aerosol formulations of diisobutyryl apomorphine |
| 11/17/2010 | EP1476428B1 Pyridyl sulfone derivatives as 5-ht6 receptor ligands |
| 11/17/2010 | EP1420821B1 Immunologically significant herpes simplex virus antigens and methods for using same |
| 11/17/2010 | EP1280486B1 Minimizing adverse experience associated with oxybutynin therapy |
| 11/17/2010 | EP1204682B1 Compositions and methods for the treatment of tumors |
| 11/17/2010 | EP1032377B1 Substituted 2-aminoacetamides and the use thereof |
| 11/17/2010 | EP0862419B2 Microencapsulated dna for vaccination and gene therapy |
| 11/17/2010 | EP0773940B2 Process for synthesis of substituted sulphoxides |
| 11/17/2010 | CN201631201U Disposable flexibly connected parallel multi-tube anti-coagulation hemostix |
| 11/17/2010 | CN1986525B 4-methoxy-1,3-phenyl disulfamide derivative and its application |
| 11/17/2010 | CN1907974B Huperzine with analgesic function and derivative thereof |
| 11/17/2010 | CN1882523B Novel phenol derivative, and anti-trypanosomiasis medicine with the phenol derivative as effective ingredient |
| 11/17/2010 | CN1863784B 2-naphthylimino-1,3-thiazine derivative |
| 11/17/2010 | CN1810803B Method for high enantiomer selection preparation of (S)-Omeprazole |
| 11/17/2010 | CN101889086A Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 11/17/2010 | CN101889015A Pyrimidine substituted purine derivatives |
| 11/17/2010 | CN101889013A Fluoroalkyl tetrabenazine carbinol compounds as imaging agents and probes |
| 11/17/2010 | CN101889011A Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3- carboxylic acid amides |
| 11/17/2010 | CN101889010A Isoxazolo-pyridine derivatives |
| 11/17/2010 | CN101889009A Inhibitors of c-fms kinase |
| 11/17/2010 | CN101889008A Quinoline derivatives for modulating DNA methylation |
| 11/17/2010 | CN101889007A Method for amplifying hematopoietic stem cells using heterocyclic compound |
| 11/17/2010 | CN101889004A Inhibitors of protein kinases |
| 11/17/2010 | CN101889000A Dibenzoazepine and dibenzooxazepine TRPA1 agonists |
| 11/17/2010 | CN101888990A Amide linked modulators of gamma-secretase |
| 11/17/2010 | CN101888989A Novel aryl potassium channel blockers and uses thereof |
| 11/17/2010 | CN101888877A Pyridine derivatives for the treatment of amyloid-related diseases |
| 11/17/2010 | CN101888846A Stable bicarbonate ion-containing drug solution |
| 11/17/2010 | CN101888845A Metal complexes incorporated within biodegradable nanoparticles and their use |
| 11/17/2010 | CN101888844A Methods and compositions for retarding weight gain associated with use of atypical antipsychotic drugs |
| 11/17/2010 | CN101888843A Fungicidal azocyclic amides |
| 11/17/2010 | CN101888842A Pharmaceutical preparation comprising stephaglabrin sulfate for treating demyelinating diseases of the nervous system and for promoting restoration of the myelin sheath of nerve fibers |
| 11/17/2010 | CN101888841A Thrombopoietin receptor agonist (TpoRA) kills acute human myeloid leukemia cells |
| 11/17/2010 | CN101888840A Method of treating polycystic kidney diseases with ceramide derivatives |
| 11/17/2010 | CN101888839A Compositions and methods for the treatment of ophthalmic conditions |
| 11/17/2010 | CN101888838A Chemical sterilant for adult male dog population control, comprising a mineral gluconate and an amino acid |
| 11/17/2010 | CN101888837A Composition of coenzyme Q10 and garlic oil to increase bioavailability of coenzyme Q-10 |
| 11/17/2010 | CN101888836A Oral drug delivery system based on poly dl- lactide-co-glycolide (plg) nano particles used for azole, moxifloxacin and rifampicin |
| 11/17/2010 | CN101888834A Oral dispersable tablet |
| 11/17/2010 | CN101888833A Dosage forms with an enterically coated core tablet |
| 11/17/2010 | CN101888829A Pharmaceutical formulation of valsartan |
| 11/17/2010 | CN101888780A Quinolone analogs and methods related thereto |
| 11/17/2010 | CN101888777A Treatment of cancer with combinations of topoisomerase inhibitors and PARP inhibitors |
| 11/17/2010 | CN101888776A Method and compositions for treatment or prevention of inflammatory conditions |
| 11/17/2010 | CN101886097A Preparation process for high purity theaflavin and application thereof in preparing anti-influenza virus medicines |
| 11/17/2010 | CN101885748A Puerarin-7-O-glucuronide as well as preparation method and application thereof |
| 11/17/2010 | CN101885735A Phenol hydroxy acid ester substituted phosphate compound, preparation method and application in medicines |
| 11/17/2010 | CN101885731A Thiophene derivative |
| 11/17/2010 | CN101885730A Compound for resisting thrombus |
| 11/17/2010 | CN101885728A Inhibitor of dipeptidyl peptidase IV and application thereof in preventing and treating diabetes |
| 11/17/2010 | CN101885726A New compound structure and preparation method and application thereof |
| 11/17/2010 | CN101885725A Pyrro-quinoline quinine sodium salt derivative and preparation method thereof |
| 11/17/2010 | CN101885722A Heterocycle alkyne and benzene compound, medicinal composition and application thereof |
| 11/17/2010 | CN101885721A Pyrrole derivatives serving as CCR5 antagonists, method for preparing same and application thereof |
| 11/17/2010 | CN101885718A Iguratimod crystal habit and composition thereof |
| 11/17/2010 | CN101885717A Iguratimod crystal habit and composition thereof |
| 11/17/2010 | CN101885697A Preparation method of Oxiracetam, product of Oxiracetam and use of product |
| 11/17/2010 | CN101885689A Fat soluble dual-core cobalt (III) anti-tumor coordination compound and preparation method thereof |
| 11/17/2010 | CN101885684A Aromatic acid pro-drug with nitrogen monoxide donor, and preparation method and application thereof |
| 11/17/2010 | CN101885676A Reduction anthraquinone compound with antibacterial activity |
| 11/17/2010 | CN101884811A Bone grafting material of gradient porous beta-TCP with bioactivity and anti-infection effect, preparation method and application thereof |
| 11/17/2010 | CN101884794A Application of S100A16 gene in preparing medicaments for treating insulin resistance |
| 11/17/2010 | CN101884791A Latrozole co-ground material, preparation method thereof and medicament composition having same |
| 11/17/2010 | CN101884789A Ctgf as target for the therapy of diabetic nephropathy |
| 11/17/2010 | CN101884784A Bv8 nucleic acids and polypeptides with mitogenic activity |
| 11/17/2010 | CN101884781A Pharmaceutical composition for preventing or treating rejection reaction of organ or tissue transplantation or graft versus host reaction of bone marrow transplantation |
| 11/17/2010 | CN101884776A Chinese preparation for treating hand-foot-and-mouth diseases |
| 11/17/2010 | CN101884775A Traditional Chinese medicine embrocation capable of prompting hair to be regenerated |
| 11/17/2010 | CN101884759A Kidney-warming, yang-strengthening and health-preserving medicinal liquor and preparation method thereof |
| 11/17/2010 | CN101884754A External Chinese medicinal preparation for treating gynecological inflammation |
| 11/17/2010 | CN101884752A Chinese medicinal preparation for navel plaster and preparation method thereof |
| 11/17/2010 | CN101884742A Health preserving medicinal wine for strengthening waist and sinews and preparation method thereof |
| 11/17/2010 | CN101884741A Health preserving medicinal wine for nourishing yin and strengthening bones and preparation method thereof |
| 11/17/2010 | CN101884740A Chinese herb preparation for drug rehabilitation |
| 11/17/2010 | CN101884721A Traditional Chinese medicine for preventing and controlling respiratory diseases of animals |
| 11/17/2010 | CN101884720A Wine for washing scabies |
| 11/17/2010 | CN101884707A Liquid for rapidly dispelling off color on face |
| 11/17/2010 | CN101884689A External medicament for treating piles |
| 11/17/2010 | CN101884687A Specific medicament for treating empyrosis and preparation method thereof |
| 11/17/2010 | CN101884656A Traditional Chinese medical composition, preparation method thereof and use thereof |